venture capital Archives

Conceptual illustration of robotic arms automating drug manufacturing, with a giant glass vessel pouring into bioreactors against the San Francisco skyline.

Multiply Labs Raises $75 Million as Physical AI Takes Aim at Biotech’s Manufacturing Bottleneck -( $AZN $KYTX $LEGN $NVS $TER )

by John F. Heerdink, Jr. October 11, 2026 694Views 0Likes

Backed by AstraZeneca and Teradyne, the robotics company is betting that the next breakthrough in medicine will need a breakthrough on the factory floor. Artificial intelligence can help design a promising medicine. It cannot deliver a dose by admiring its own calculations.…

Comic-style illustration titled “The Fund-Raisers!” showing investors, a biotech innovation globe, a Forbion shield and laboratories, with a speech bubble announcing “2.6 billion raised.”

Forbion’s $2.6 Billion Biotech Raise Signals Smart Money Is Backing the Next Wave of Medicines -( $IBB $LLY $XBI )

by John F. Heerdink, Jr. October 8, 2026 687Views 0Likes

Two new funds, institutional backing and a pharmaceutical heavyweight give the European life sciences investor fresh capital to turn promising science into investable businesses. Biotechnology has never suffered from a shortage of ambitious ideas. Financing them is another matter. Forbion has just…

Stylized illustration of NVIDIA CEO Jensen Huang on Wall Street, surrounded by glowing AI chips, venture capital symbols and a $679 billion funding wave flowing toward an NVIDIA AI ecosystem

AI’s $679 Billion Funding Wave: Why NVIDIA and Wall Street Could Benefit From Venture Capital’s Boom -( $AMZN $GOOGL $MSFT $NVDA )

by John F. Heerdink, Jr. October 8, 2026 580Views 0Likes

Private-market investment is financing the next generation of AI businesses, and public-market investors may not need an invitation to Silicon Valley’s inner circle to participate. Wall Street’s next growth engine may already be under construction, financed by many willing to write enormous…

Zenflow’s $52 Million Raise Gives Its BPH Breakthrough Commercial Muscle -( $HSBC $TRIN )

by John F. Heerdink, Jr. October 7, 2026 268Views 0Likes

An exclusive U.S. distribution agreement with Cook Medical adds an established sales channel to Zenflow’s FDA-approved Spring System, and strengthens the case for a new approach to enlarged-prostate treatment. Zenflow has reached a consequential stage in the medical-device business: its technology is…

Fortell’s AI Hearing Aid Could Turn a Staid Medical-Device Category Into a Premium Technology Market -( $BLFY $GNNDY $GOOGL $NVDA $SONVY )

by John F. Heerdink, Jr. August 14, 2026 490Views 0Likes

The next compelling AI investment story may not sit in a data center. It may sit discreetly behind the ear. Fortell, a privately held AI-hearing-aid company, is positioning itself at the intersection of custom silicon, machine learning, clinical care, and an enormous…

Invitation (11am ET, Friday, August 7: ‘The Next Wave of AI Growth – Cheap, Opensource, Safe, and Sovereign’ ( $NVDA $GOOG )

by John F. Heerdink, Jr. August 7, 2026 668Views 0Likes

“Sovereign AI” is quickly moving from buzzword to policy priority as governments realize that renting intelligence from hyperscale clouds is not a long‑term strategy when data, defense, healthcare, and financial systems are at stake. Platforms like Seven Boson Group Ltd. are positioning…

Google’s Eric Schmidt Says Kill the Switch; Sovereign AI Says Build Your Own Control Room -( $GOOG $GOOGL )

by John F. Heerdink, Jr. August 6, 2026 518Views 0Likes

Wall Street is finally admitting what Eric Schmidt just said out loud: if AI is going to be powerful enough to “pull the plug” on us, it had better be built in a way that lets nations and investors keep their hand…

Mira Murati’s Thinking Machines: The AI Lab That Raised Billions Before Saying “Hello, World” -( $AMD $CSCO $NVDA )

by John F. Heerdink, Jr. March 10, 2026 552Views 0Likes

In a funding climate where many startups now need revenue, a roadmap, and perhaps a minor miracle to get a Series A, Mira Murati’s Thinking Machines Lab just secured roughly $2 billion at a $12 billion valuation before launching a single product.…

Inside Biopharma’s 2025 Deal Wave: Record Licensing, Big Pharma M&A and a Frozen IPO Market -( $JPM $IBB $XBI $LLY $MRK $NVS $PFE )

by John F. Heerdink, Jr. January 21, 2026 567Views 0Likes

Biopharma spent 2025 behaving like a sector that has finally read the fine print on the cost of capital—and decided to let someone else pick up the bar tab. Licensing and M&A stepped into the role IPOs used to play, and did…

Tag: venture capital

Multiply Labs Raises $75 Million as Physical AI Takes Aim at Biotech’s Manufacturing Bottleneck -( $AZN $KYTX $LEGN $NVS $TER )

Forbion’s $2.6 Billion Biotech Raise Signals Smart Money Is Backing the Next Wave of Medicines -( $IBB $LLY $XBI )

AI’s $679 Billion Funding Wave: Why NVIDIA and Wall Street Could Benefit From Venture Capital’s Boom -( $AMZN $GOOGL $MSFT $NVDA )

Zenflow’s $52 Million Raise Gives Its BPH Breakthrough Commercial Muscle -( $HSBC $TRIN )

Fortell’s AI Hearing Aid Could Turn a Staid Medical-Device Category Into a Premium Technology Market -( $BLFY $GNNDY $GOOGL $NVDA $SONVY )

Invitation (11am ET, Friday, August 7: ‘The Next Wave of AI Growth – Cheap, Opensource, Safe, and Sovereign’ ( $NVDA $GOOG )

Google’s Eric Schmidt Says Kill the Switch; Sovereign AI Says Build Your Own Control Room -( $GOOG $GOOGL )

Mira Murati’s Thinking Machines: The AI Lab That Raised Billions Before Saying “Hello, World” -( $AMD $CSCO $NVDA )

Inside Biopharma’s 2025 Deal Wave: Record Licensing, Big Pharma M&A and a Frozen IPO Market -( $JPM $IBB $XBI $LLY $MRK $NVS $PFE )

Your Guide To Staying Informed In The Markets